Literature DB >> 9461107

Fracture risk among patients with urolithiasis: a population-based cohort study.

L J Melton1, C S Crowson, S Khosla, D M Wilson, W M O'Fallon.   

Abstract

In a population-based retrospective cohort study, 624 Rochester, Minnesota residents with an initial symptomatic episode of urolithiasis in 1950 to 1974 were followed for 11,909 person-years for subsequent age-related fractures. During this period of observation, the number of patients with a first vertebral fracture was over four times the number expected on the basis of vertebral fracture incidence rates in the general population of Rochester [standardized morbidity ratio (SMR), 4.3; 95% confidence interval, 3.4 to 5.3]. The risk of vertebral fracture was elevated among men as well as women, and was associated with increasing age and with the use of corticosteroids for more than six months. However, vertebral fracture risk was increased nearly fourfold (SMR 3.9; 95% confidence interval, 3.0 to 4.9) among the urolithiasis patients without such exposure, which suggests that corticosteroids do not completely account for the association with vertebral fractures. There was no increase in the risk of hip, pelvis, proximal humerus or distal forearm fractures in this cohort of patients, and their survival was not impaired. Additional studies are needed to define the pathophysiology of vertebral fractures among patients with urolithiasis.

Entities:  

Mesh:

Year:  1998        PMID: 9461107     DOI: 10.1046/j.1523-1755.1998.00779.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  44 in total

Review 1.  Bone disease and idiopathic hypercalciuria.

Authors:  Joseph E Zerwekh
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

2.  Association between osteoporosis and urinary calculus: evidence from a population-based study.

Authors:  J J Keller; C-C Lin; J-H Kang; H-C Lin
Journal:  Osteoporos Int       Date:  2012-05-17       Impact factor: 4.507

Review 3.  Nephrolithiasis.

Authors:  Elaine M Worcester; Fredric L Coe
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

4.  Expression of fibroblast growth factor 23, vitamin D receptor, and sclerostin in bone tissue from hypercalciuric stone formers.

Authors:  Viviane Barcellos Menon; Rosa Maria Affonso Moysés; Samirah Abreu Gomes; Aluizio Barbosa de Carvalho; Vanda Jorgetti; Ita Pfeferman Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 8.237

5.  Bisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug.

Authors:  Gerolamo Bianchi; Andrea Giusti; Giulio Pioli; Antonella Barone; Ernesto Palummeri; Giuseppe Girasole
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-02       Impact factor: 5.346

6.  The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison.

Authors:  Antonia Fabris; Pietro Manuel Ferraro; Gabriele Comellato; Chiara Caletti; Francesco Fantin; Gianluigi Zaza; Mauro Zamboni; Antonio Lupo; Giovanni Gambaro
Journal:  J Nephrol       Date:  2014-09-30       Impact factor: 3.902

7.  Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy.

Authors:  Kara L Watts; Abhishek Srivastava; Wilson Lin; Daniel Schoenfeld; Matthew Abramowitz; Joshua M Stern
Journal:  Urolithiasis       Date:  2019-02-12       Impact factor: 3.436

8.  Stones: Bone health in patients with kidney stones.

Authors:  Miguel Angel Arrabal-Polo; Miguel Arrabal-Martin
Journal:  Nat Rev Urol       Date:  2014-12-09       Impact factor: 14.432

9.  Stones, bones, and cardiovascular groans.

Authors:  Eric N Taylor
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-29       Impact factor: 8.237

Review 10.  Bone mineral content in calcium renal stone formers.

Authors:  A Trinchieri
Journal:  Urol Res       Date:  2005-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.